跳至主要内容
临床试验/NCT04686721
NCT04686721Unknown不适用

A Retrospective and Prospective Observational, Multicentric, Case-control Clinical Study for the Evaluation of Tracheal Stenosis Among Patients With COVID-19 and Prolonged Intubation or Tracheostomy.

Istituto Clinico Humanitas1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年12月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Clinical presentation of tracheal stenosis

研究概览

简要总结

Define the actual incidence of tracheal stenosis in patients who underwent either prolonged intubation or tracheostomy and to compare incidence, clinical course and outcome between COVID-19 and non-COVID-19 patients.

详细描述

The TS1 is a national observational, multicentric, case-control clinical aiming at defining the actual incidence of tracheal stenosis in patients with COVID-19 that underwent prolonged intubation or tracheal stenosis.

Information regarding anamnestic data, demographics, smoking or alcohol habits, comorbidity, previous history of prolonged ventilation or tracheostomy, and data about intensive care unit stay and treatment will be collected before discharging patients from hospital.

All patients enrolled will perform an initial evaluation with a chest CT scan without contrast-enhancing at 2 months from hospital discharge along with pulmonary function test. If tracheal stenosis is detected, treatment according to currently available guidelines will be performed.

Patients with no signs of clinical, functional and radiological evidence of tracheal stenosis will perform a 3 and 6 months clinical follow-up from initial evaluation.

A chest CT scan with pulmonary function test will be administered if symptoms of tracheal stenosis arise during clinical follow-up. If necessary, treatment according to currently available guidelines will be performed.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • prolonged intubation, defined as the permanence of naso or oro- tracheal tube for more than 7 days
  • tracheostomy, whether surgical or percutaneous
  • minimum of 2 months follow-up from hospital discharge
  • Positivity to SARS-CoV-2 infection confirmed using PCR on either nasal swab or bronchoalveolar lavage will be not an inclusion criterion; patients tested negative will be used as a control group

排除标准

  • Pediatric patients (< 18 years of age)
  • Patients without a minimum of 2 months follow-up from hospital discharge

结局指标

主要结局

Clinical presentation of tracheal stenosis

时间窗: 8 months

Describe symptoms most commonly associated with tracheal stenosis

Clinical course of tracheal stenosis

时间窗: 8 months

Analyse the clinical evolution of tracheal stenosis during follow-up

Outcome of tracheal stenosis

时间窗: 8 months

Collect data on morbidity and mortality of tracheal stenosis

Incidence of tracheal stenosis following either prolonged intubation or tracheostomy in COVID-19 patients

时间窗: 8 months

Observe how many subject in the population at risk will develop tracheal stenosis during follow-up

次要结局

  • Identification of demographic factor with a predictive and prognostic value for tracheal stenosis(8 months)
  • Identification of instrumental factor with a predictive and prognostic value for tracheal stenosis(8 months)
  • Compare COVID-19 and non-COVID-19 patients at risk of developing tracheal stenosis(8 months)
  • Identification of radiological factor with a predictive and prognostic value for tracheal stenosis(8 months)
  • Identification of clinical factor with a predictive and prognostic value for tracheal stenosis(8 months)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验